/entrackr/media/media_files/2025/06/11/YPuXvpKo74yk1NpUWa4s.png)
Deeptech manufacturing startup Leumas has raised $2.2 million in a seed funding round led by Capital 2B, a deeptech-focused fund backed by Info Edge and Temasek along with participation from Capital-A and Anicut Capital.
The proceeds will be used to expand its R&D capabilities, scale on-demand manufacturing infrastructure, and launch pilot deployments of dedicated factories for wellness and pharma brands, Leumas said in a press release.
Co-founded in 2016 by Subhajit Biswas and Nitesh K, Leumas offers on-demand manufacturing and factory-as-a-service models for wellness and pharma brands. Its solution is built on software-defined, modular robot factories that radically improve manufacturing and business outcomes - from development to commercial production. By combining automation, software intelligence, and R&D, it helps brands scale quickly, maintain quality, and reduce risk.
According to Leumas, its core product is cyber-physical manufacturing technology: software-driven, modular production lines that integrate AI-led robotics, vision-based quality systems, and autonomous operations to ensure optimal production output and regulatory compliance.
As per market research, the outsourced development and manufacturing market for pharma and wellness is expected to exceed $400 billion by 2030.
Over the past year, Leumas claims to have co-developed its manufacturing solution with leading wellness brands and has helped scale more than 120 products across India, the US, and MENA. It has also signed agreements with prominent pharma and food research institutions to build dedicated factory capacities using its modular factory solution.